* Chimerix Inc CMRX.OQ reported a quarterly adjusted loss
of 27
cents per share for the quarter ended in September, lower than
the same quarter last year, when the company reported EPS of
$2.75. The mean expectation of seven analysts for the quarter
was for a loss of 23 cents per share. Wall Street expected
results to range from -26 cents to -20 cents per share.
* Revenue fell 100% to $11.00 thousand from a year ago;
analysts
expected $76.43 thousand.
* Chimerix Inc's reported EPS for the quarter was a loss
of 27
cents.
* The company reported a quarterly loss of $23.8 million.
* Chimerix Inc shares had risen by 0.0% this quarter and
lost 48.4% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 0.6%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* Wall Street's median 12-month price target for Chimerix
Inc is
$7.00
This summary was machine generated from LSEG data November 2 at
01:32 p.m. UTC. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2023 -0.23 -0.27 Missed
Jun. 30 2023 -0.24 -0.21 Beat
Mar. 31 2023 -0.25 -0.24 Beat
Dec. 31 2022 -0.24 -0.24 Met